Bird & Bird advised Fonds Patient Autonome and Uniqa Ventures on their €4 million financing round of Fizimed

International law firm Bird & Bird advised Fonds Patient Autonome, managed by Bpifrance, and Uniqa Ventures on their participation in the €4 million financing round of Fizimed, a femtech dedicated to women's health.

The Fonds Patient Autonome and Uniqa Ventures led the financing round, in which UI Investissement also participated.

The Bird & Bird team advising Fonds Patient Autonome and Uniqa Ventures comprised of partner Carole Bodin and associate Pascaline Sagot, who advised on the corporate aspects, with partner Alexandre Vuchot and associate Caroline Arrighi-Savoie advising on the regulatory aspects.

The company was advised by Charles Russell Speechlys. The team comprised of partner Renaud Ferry and Counsel Orlando Vignoli Neto.

News & Deals

More News & Deals

Deal

Bird & Bird advises Vanagon Ventures on seed investment in Particula

May 07 2025

Read More

Deal

Bird & Bird advises BRIDOR on its global bakery transaction in Australia

May 07 2025

Read More

News

Bird & Bird and the Finnish Olympic Committee Enter Partnership

May 07 2025

Read More

News

Bird & Bird strengthens Corporate team with new partner Shahin Foroughian in Singapore

May 07 2025

Read More

News

Bird & Bird hires three new partners into international Corporate Group

May 06 2025

Read More

Deal

Bird & Bird advises Gamma on its admission to the Main Market of the London Stock Exchange

May 02 2025

Read More